These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2786210)

  • 1. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.
    Nunberg JH; Doyle MV; York SM; York CJ
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4240-3. PubMed ID: 2786210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine.
    Asgary V; Shoari A; Afshar Moayad M; Shafiee Ardestani M; Bigdeli R; Ghazizadeh L; Khosravy MS; Panahnejad E; Janani A; Bashar R; Abedi M; Ahangari Cohan R
    Viral Immunol; 2018; 31(1):47-54. PubMed ID: 29328884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine.
    Zhang W; Cheng N; Wang Y; Zheng X; Zhao Y; Wang H; Wang C; Han Q; Gao Y; Shan J; Yang S; Xia X
    Virus Res; 2019 Sep; 270():197638. PubMed ID: 31173772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine.
    Schijns VE; Claassen IJ; Vermeulen AA; Horzinek MC; Osterhaus AD
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():55-63. PubMed ID: 8113740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine.
    Wang X; Bao M; Wan M; Wei H; Wang L; Yu H; Zhang X; Yu Y; Wang L
    Vaccine; 2008 Mar; 26(15):1893-901. PubMed ID: 18321616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
    Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
    Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX™ adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques.
    DiStefano D; Antonello JM; Bett AJ; Medi MB; Casimiro DR; ter Meulen J
    Vaccine; 2013 Oct; 31(42):4888-93. PubMed ID: 23941913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice.
    Xiao XX; Zhang Y; Liu JX; Wei QL; Yin XP
    Arch Virol; 2016 Mar; 161(3):685-91. PubMed ID: 26650039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants.
    Shi W; Kou Y; Xiao J; Zhang L; Gao F; Kong W; Su W; Jiang C; Zhang Y
    Vaccine; 2018 Aug; 36(33):5020-5029. PubMed ID: 30037417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus atrophaeus inactivated spores as a potential adjuvant for veterinary rabies vaccine.
    Oliveira-Nascimento L; Caricati AT; Abdulack-Lopes F; Neves LC; Caricati CP; Penna TC; Stephano MA
    Vaccine; 2012 May; 30(23):3351-4. PubMed ID: 22449426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Activity of Inactivated Rabies Vaccine Using Flagellin-Based Adjuvant.
    Sokol OO; Nikitin NA; Evtushenko EA; Karpova OV; Matveeva IN; Gryn SA; Popova VM; Ivanov IV; Fedorov YN; Litenkova IY
    Biochemistry (Mosc); 2024 Mar; 89(3):574-582. PubMed ID: 38648774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Am J Vet Res; 2003 Apr; 64(4):499-505. PubMed ID: 12693543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A semi-quantitative serological method to assess the potency of inactivated rabies vaccine for veterinary use.
    Liu Y; Zhang S; Zhang F; Hu R
    Virol Sin; 2012 Aug; 27(4):259-64. PubMed ID: 22899435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of free-ranging Pennsylvania raccoons (Procyon lotor) with inactivated rabies vaccine.
    Brown CL; Rupprecht CE
    J Wildl Dis; 1990 Apr; 26(2):253-7. PubMed ID: 2338729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of Egyptian fruit bats (Rousettus aegyptiacus) with monovalent inactivated rabies vaccine.
    Peters C; Isaza R; Heard DJ; Davis RD; Moore SM; Briggs DJ
    J Zoo Wildl Med; 2004 Mar; 35(1):55-9. PubMed ID: 15193074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency testing of inactivated rabies vaccines using a serological method.
    Kamphuis E; Krämer B; Schildger H; Duchow K
    Dev Biol (Basel); 2012; 134():23-7. PubMed ID: 22888591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice.
    Yu P; Yan J; Wu W; Tao X; Lu X; Liu S; Zhu W
    Virol J; 2018 Nov; 15(1):174. PubMed ID: 30424815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SINGLE- VERSUS DOUBLE-DOSE RABIES VACCINATION IN CAPTIVE AFRICAN WILD DOGS (LYCAON PICTUS).
    Connolly M; Thomas P; Woodroffe R; Raphael BL
    J Zoo Wildl Med; 2015 Dec; 46(4):691-8. PubMed ID: 26667524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.